** Shares of biotechnology firm Windtree Therapeutics WINT.O down 8.30% at about $0.49
** CEO Craig Fraser to retire, effective Dec. 1
** Fraser to remain on the board as chairman
** Jed Latkin, current director, appointed as CEO
** Including session gains, stock had fallen 96.1% YTD
(Reporting by Nithyashree R B)
((NithyashreeRB@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。